Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective studyYajing Chi, Huihui Li, Mu Su et al.|eLife|2023Cited by 10
Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World StudyJie Huang, Huihui Li, Baoxuan Zhang et al.|Clinical Breast Cancer|2024Cited by 6
Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trialXiaochu Man, Jie Huang, Shujuan Sun et al.|Clinical and Translational Medicine|2024Cited by 6
Dynamic Analysis of Circulating Tumor DNA to Predict the Prognosis and Monitor the Treatment Response of Patients with Metastatic Triple-negative Breast Cancer: a prospective studyYajing Chi, Huihui Li, Mu Su et al.|medRxiv|2023Cited by 1
Author response: Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective studyYajing Chi, Huihui Li, Mu Su et al.|Unknown|2023Cited by 0